Ishita Drugs & Industries Ltd EPS
Ishita Drugs & Industries Ltd
NSE: ISHITADRUGS
EPS
Key Highlights
- The Earning per Share of Ishita Drugs & Industries Ltd is ₹ 2.6 as of 28 Jul 26 The earning per share of Ishita Drugs & Industries Ltd changed from ₹ 0.49 to ₹ 0.59 over 8 quarters. This represents a CAGR of 9.73% .
Historical Earning per Share of Ishita Drugs & Industries Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Ishita Drugs & Industries Ltd
Company Fundamentals for Ishita Drugs & Industries Ltd
Market Cap
22 Cr
EPS
2.6
P/E Ratio (TTM)
28.8
P/B Ratio (TTM)
1.9
Day’s High
74.9
Day’s Low
74.8
DTE
0.0
ROE
6.7
52 Week High
90.85
52 Week Low
66.0
ROCE
9.8
Market Price of Ishita Drugs & Industries Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 28 Jul 2026 | 74.9 |
| 27 Jul 2026 | 74.06 |
| 24 Jul 2026 | 74.05 |
| 23 Jul 2026 | 71.96 |
| 21 Jul 2026 | 71.04 |
| 20 Jul 2026 | 71.79 |
| 17 Jul 2026 | 71.08 |
| 16 Jul 2026 | 72.5 |
| 15 Jul 2026 | 73 |
| 14 Jul 2026 | 74 |
BlinkX Score for Ishita Drugs & Industries Ltd
Asset Value vs Market Value of Ishita Drugs & Industries Ltd
Market Value
₹ 22
Asset Value
Value addition
1.0 X
₹ 11
* All values are in ₹ crores
Competitive Comparison of EPS
| Company | Market Cap | EPS |
|---|
Ishita Drugs & Industries Ltd | 22.4 | 2.6 |
Sun Pharmaceutical Industries Ltd | 474397 | 51.8 |
Divis Laboratories Ltd | 196990 | 98.81 |
Torrent Pharmaceuticals Ltd | 186354 | 57.62 |
Cipla Ltd | 116705 | 44.3 |
Zydus Lifesciences Ltd | 109686 | 54.46 |
| Company | |
|---|---|
| Ishita Drugs & Industries Ltd | 22.4 |
| Sun Pharmaceutical Industries Ltd | 474397 |
| Divis Laboratories Ltd | 196990 |
| Torrent Pharmaceuticals Ltd | 186354 |
| Cipla Ltd | 116705 |
| Zydus Lifesciences Ltd | 109686 |
Historical Market Cap of Ishita Drugs & Industries Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Ishita Drugs & Industries Ltd
Historical Revenue of Ishita Drugs & Industries Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Ishita Drugs & Industries Ltd
Historical EBITDA of Ishita Drugs & Industries Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Ishita Drugs & Industries Ltd
Historical Net Profit of Ishita Drugs & Industries Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Ishita Drugs & Industries Ltd
Dividend Payout Over Time
Ishita Drugs & Industries Ltd News Hub
Ishita Drugs & Industries standalone net profit rises 7.14% in the June 2024 quarter
Net profit of Ishita Drugs & Industries rose 7.14% to Rs 0.15 crore in the quarter ended June 2024 a
Read more
14 Aug 24
Ishita Drugs & Industries to declare Quarterly Result
Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 13 August
Read more
10 Aug 24
Ishita Drugs & Industries AGM scheduled
Ishita Drugs & Industries announced that the Annual General Meeting (AGM) of the company will be hel
Read more
28 Aug 24
Ishita Drugs & Industries standalone net profit declines 9.52% in the September 2024 quarter
Net profit of Ishita Drugs & Industries declined 9.52% to Rs 0.19 crore in the quarter ended Septemb
Read more
13 Nov 24
